These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 32362386)
1. Structure-activity relationship analyses of fusidic acid derivatives highlight crucial role of the C-21 carboxylic acid moiety to its anti-mycobacterial activity. Singh K; Kaur G; Shanika PS; Dziwornu GA; Okombo J; Chibale K Bioorg Med Chem; 2020 Jul; 28(13):115530. PubMed ID: 32362386 [TBL] [Abstract][Full Text] [Related]
2. Semisynthetic Antimycobacterial C-3 Silicate and C-3/C-21 Ester Derivatives of Fusidic Acid: Pharmacological Evaluation and Stability Studies in Liver Microsomes, Rat Plasma, and Njoroge M; Kaur G; Espinoza-Moraga M; Wasuna A; Dziwornu GA; Seldon R; Taylor D; Okombo J; Warner DF; Chibale K ACS Infect Dis; 2019 Sep; 5(9):1634-1644. PubMed ID: 31309823 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and conformational analysis of fusidic acid side chain derivatives in relation to antibacterial activity. Duvold T; Sørensen MD; Björkling F; Henriksen AS; Rastrup-Andersen N J Med Chem; 2001 Sep; 44(19):3125-31. PubMed ID: 11543681 [TBL] [Abstract][Full Text] [Related]
4. An antibacterial hydroxy fusidic acid analogue from Acremonium crotocinigenum. Evans L; Hedger JN; Brayford D; Stavri M; Smith E; O'Donnell G; Gray AI; Griffith GW; Gibbons S Phytochemistry; 2006 Oct; 67(19):2110-4. PubMed ID: 16930645 [TBL] [Abstract][Full Text] [Related]
5. Pharmacologically active metabolites, combination screening and target identification-driven drug repositioning in antituberculosis drug discovery. Kigondu EM; Wasuna A; Warner DF; Chibale K Bioorg Med Chem; 2014 Aug; 22(16):4453-61. PubMed ID: 24997576 [TBL] [Abstract][Full Text] [Related]
6. Metabolic profiling for the discovery of two rare fusidane-type heterodimers from the fungal endophyte Acremonium pilosum F47. Lin P; Tian C; Peng XP; Lou HX; Li G Steroids; 2023 Apr; 192():109188. PubMed ID: 36738818 [TBL] [Abstract][Full Text] [Related]
7. Formulation and Molecular Dynamics Simulations of a Fusidic Acid Nanosuspension for Simultaneously Enhancing Solubility and Antibacterial Activity. Omolo CA; Kalhapure RS; Agrawal N; Rambharose S; Mocktar C; Govender T Mol Pharm; 2018 Aug; 15(8):3512-3526. PubMed ID: 29953816 [TBL] [Abstract][Full Text] [Related]
8. Three new fusidic acid derivatives and their antibacterial activity. Zhang S; Wang S; Zhang Q; Chang CW; Zhan J Bioorg Med Chem Lett; 2015 May; 25(9):1920-4. PubMed ID: 25824664 [TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility of Mycobacterium tuberculosis to fusidic acid. Cicek-Saydam C; Cavusoglu C; Burhanoglu D; Hilmioglu S; Ozkalay N; Bilgic A Clin Microbiol Infect; 2001 Dec; 7(12):700-2. PubMed ID: 11843915 [TBL] [Abstract][Full Text] [Related]
10. Antituberculosis compounds from a deep-sea-derived fungus Aspergillus sp. SCSIO Ind09F01. Luo X; Zhou X; Lin X; Qin X; Zhang T; Wang J; Tu Z; Yang B; Liao S; Tian Y; Pang X; Kaliyaperumal K; Li JL; Tao H; Liu Y Nat Prod Res; 2017 Aug; 31(16):1958-1962. PubMed ID: 28068839 [TBL] [Abstract][Full Text] [Related]
11. Integration of multiscale molecular modeling approaches with the design and discovery of fusidic acid derivatives. Lu J; Ni JX; Wang JA; Liu ZY; Shang KL; Bi Y Future Med Chem; 2019 Jun; 11(12):1427-1442. PubMed ID: 31304828 [No Abstract] [Full Text] [Related]
12. Synthesis and biological characterisation of ester and amide derivatives of fusidic acid as antiplasmodial agents. Espinoza-Moraga M; Singh K; Njoroge M; Kaur G; Okombo J; De Kock C; Smith PJ; Wittlin S; Chibale K Bioorg Med Chem Lett; 2017 Feb; 27(3):658-661. PubMed ID: 28012840 [TBL] [Abstract][Full Text] [Related]
13. Comparative in-vitro activities of ten fluoroquinolones and fusidic acid against Mycobacterium spp. Van Caekenberghe D J Antimicrob Chemother; 1990 Sep; 26(3):381-6. PubMed ID: 2228828 [TBL] [Abstract][Full Text] [Related]
14. 17S,20S-Methanofusidic acid, a new potent semi-synthetic fusidane antibiotic. Duvold T; Jørgensen A; Andersen NR; Henriksen AS; Dahl Sørensen M; Björkling F Bioorg Med Chem Lett; 2002 Dec; 12(24):3569-72. PubMed ID: 12443778 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and anti-mycobacterial activities of triazoloquinolones. Carta A; Palomba M; Briguglio I; Corona P; Piras S; Jabes D; Guglierame P; Molicotti P; Zanetti S Eur J Med Chem; 2011 Jan; 46(1):320-6. PubMed ID: 21145625 [TBL] [Abstract][Full Text] [Related]
17. Biosynthesis of helvolic acid and identification of an unusual C-4-demethylation process distinct from sterol biosynthesis. Lv JM; Hu D; Gao H; Kushiro T; Awakawa T; Chen GD; Wang CX; Abe I; Yao XS Nat Commun; 2017 Nov; 8(1):1644. PubMed ID: 29158519 [TBL] [Abstract][Full Text] [Related]
18. Fusidic acid derivatives from the endophytic fungus Tian C; Gao H; Peng XP; Li G; Lou HX J Asian Nat Prod Res; 2021 Dec; 23(12):1148-1155. PubMed ID: 33455458 [TBL] [Abstract][Full Text] [Related]
19. Investigation of 4-amino-5-alkynylpyrimidine-2(1H)-ones as anti-mycobacterial agents. Garg G; Pande M; Agrawal A; Li J; Kumar R Bioorg Med Chem; 2016 Apr; 24(8):1771-7. PubMed ID: 26988804 [TBL] [Abstract][Full Text] [Related]
20. Antimicrobial activity and mechanisms of resistance to cephalosporin P1, an antibiotic related to fusidic acid. O'Neill AJ; Bostock JM; Moita AM; Chopra I J Antimicrob Chemother; 2002 Dec; 50(6):839-48. PubMed ID: 12461002 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]